Quantcast

Industry news that matters to you.  Learn more

Archives for July 2010

Pacific Biomarkers Launches New Website

Pacific Biomarkers, Inc., a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, unveiled its new website on Friday, July 23. The site, www.PacBio.com, incorporates numerous features to make browsing a more fruitful experience for the Company’s current and potential customers and investors.

Biomarkers “Indispensible” in Cancer Drug Development, says Quintiles

CRO Quintiles says biomarkers give insight into cancer drug candidates’ efficacy earlier in the development process, reducing trial costs and duration.

CWRU Dental Researchers Discover Human Beta Defensins-3 Ignite in Oral Cancer Growth

Detecting oral cancer in its earliest stages can save the lives of the nearly 40,500 people diagnosed annually. But early detection has been difficult.

Case Western Reserve University School of Dental Medicine researchers discovered a biomarker, called human beta defensin-3 (hBD-3), which may serve as an early warning. The defensin is present in all oral cancers and associated with the early stages of oral cancer.

USC Studies Nitric Oxide’s Link to Asthma

Children with elevated levels of exhaled nitric oxide (FeNO) are at increased risk for developing asthma, particularly among children without a parental history of the disease, a study by researchers at the Keck School of Medicine of USC has found. The study is published in the European Respiratory Journal.

Thermo Fisher Scientific and Intrinsic Bioprobes Announce Alliance in Mass Spectrometric Immunoassay Workflow Development

Thermo Fisher Scientific, Inc., the world leader in serving science, and Intrinsic Bioprobes (IBI) Inc., today announced an alliance to co-develop and market a mass spectrometry solution that will enable researchers to perform quantitative, high-throughput, high-resolution protein biomarker assays. The solution couples the specificity of immunoenrichment with the sensitivity and quantitative capability of mass spectrometry to provide researchers with a more complete, higher-resolution view of the proteome. Initially, via an exclusive reseller agreement, the solution will be applied to the detection of human parathyroid hormone (PTH) and its variants, which may be useful as biomarkers for bone diseases and diseases of the endocrine system.